title: Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma.
abstract: BACKGROUND
  Osteosarcoma is the most common primary malignant bone tumor in children and young adults. Ganglioside GD2 has been previously found on the cell surface in various tumor types, including osteosarcomas.
  
  
  RESULTS
  In this study, forty-nine additional osteosarcoma samples from 14 individual patients were assessed for GD2 expression via immunohistochemistry, of which 47 samples were found to express GD2. In matched samples from patients, GD2 expression seen at initial biopsy was found to persist in 100% of tissues taken at recurrence.
  
  
  CONCLUSIONS
  GD2 expression was found to persist upon recurrence. These results suggest a phase 2 trial in children with recurrent osteosarcoma should provide an appropriate read out on the efficacy of anti-GD2 antibody.
authors: Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3415 Bainbridge Ave, Rosenthal Pavilion, Room 300, Bronx, NY 10467 USA.
authors: Vincent I
authors: VI
authors: Poon
authors: Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3415 Bainbridge Ave, Rosenthal Pavilion, Room 300, Bronx, NY 10467 USA.
authors: Michael
authors: M
authors: Roth
authors: Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3415 Bainbridge Ave, Rosenthal Pavilion, Room 300, Bronx, NY 10467 USA.
authors: Sajida
authors: S
authors: Piperdi
authors: Department of Orthopaedic Surgery, Montefiore Medical Center and the Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY USA.
authors: David
authors: D
authors: Geller
authors: Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3415 Bainbridge Ave, Rosenthal Pavilion, Room 300, Bronx, NY 10467 USA.
authors: Jonathan
authors: J
authors: Gill
authors: Department of Pathology, Seattle Children's Hospital and University of Washington, Seattle, WA USA.
authors: Erin R
authors: ER
authors: Rudzinski
authors: Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, and University of Washington, Seattle, WA USA.
authors: Douglas S
authors: DS
authors: Hawkins
authors: Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3415 Bainbridge Ave, Rosenthal Pavilion, Room 300, Bronx, NY 10467 USA ; Department of Pediatrics and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY USA.
authors: Richard
authors: R
authors: Gorlick
keywords: Antibody; Ganglioside GD2; Immunotherapy; Osteosarcoma
references: Nat Immunol. 2002 Nov;3(11):991-8
references: 12407406
references: Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):4968-73
references: 23479608
references: Cancer Res. 2014 Feb 1;74(3):665-74
references: 24336068
references: Mol Cell Proteomics. 2014 Sep;13(9):2213-32
references: 24855066
references: Clin Cancer Res. 1998 Sep;4(9):2135-9
references: 9748131
references: Cancer. 2014 Feb 15;120(4):548-54
references: 24166473
references: N Engl J Med. 2010 Sep 30;363(14):1324-34
references: 20879881
references: J Natl Cancer Inst. 1989 Mar 15;81(6):440-4
references: 2918552
references: Cancer Res. 2001 May 15;61(10):4244-52
references: 11358851
references: Cell Rep. 2014 Apr 10;7(1):104-12
references: 24703847
references: J Clin Invest. 2012 Jun;122(6):2066-78
references: 22585577